baber/WOPTO huggingface dataset:
Patent AU-2011329491-B2 (AU)
Title: Remote operation of a rotating control device bearing clamp and safety latch
Inventor: LINDE LEONARD C
IPC: E21B17/02
Filed: 2011-03-14
Granted: 2014-05-01
Abstract: An RCD can include a housing assembly which contains a bearing assembly and an annular seal which rotates and seals off an annulus between a tubular string and an RCD body, a remotely operable clamp device which selectively permits and prevents relative displacement between the housing assembly and the body, and a remotely operable safety latch which selectively permits and prevents unclamping of the clamp device. A method of remotely operating an RCD clamp device can include remotely operating a safety latch which selectively permits and prevents unclamping of the clamp device, and remotely operating the clamp device while the safety latch is in an unlatched position, thereby unclamping a bearing housing assembly from the RCD body. Another RCD can include a remotely operable clamp device which selectively permits access to an RCD body interior, and a remotely operable safety latch which selectively prevents unclamping of the clamp device.
Patent AU-2011336396-B2 (AU)
Title: In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
Inventor: MCBRIDE WILLIAM J
IPC: A61K51/10
Filed: 2011-12-02
Granted: 2016-02-04
Abstract: The present application discloses compositions and methods of synthesis and use involving click chemistry reactions for
Patent AU-2011354703-B2 (AU)
Title: Stent delivery system with pusher assembly
Inventor: BUECHE KENNETH M
IPC: A61F2/966
Filed: 2011-05-27
Granted: 2014-09-04
Abstract: A pusher assembly for a stent delivery device includes a distal end of an elongate inner member and a stent-engaging member having a proximal end and a distal end. The proximal end of the stent-engaging member is at least partially inside the distal end of the elongate inner member. The stent-engaging member includes a portion that radially outwardly extends towards the distal end of the stent-engaging member. The stent-engaging member is configured to move a stent when distally advanced and is configured to not move a stent when proximally retracted.
Patent AU-2011378567-B2 (AU)
Title: Vehicle Vibration Reduction Apparatus
Inventor: MURATA KIYOHITO
IPC: F16F15/126
Filed: 2011-10-05
Granted: 2015-09-03
Abstract: This vehicular vibration-reduction device (1) comprises: an inertial mass body (30) that is connected to the rotary shaft (13) of a power-transmitting device (5), which is capable of transmitting rotary power from a travel drive source (4) of a vehicle (2) to the driving wheels (10) thereof, in a manner such that power can be transmitted to the inertial mass body; and a switching device (40) that is provided in the power-transmitting path between the rotary shaft (13) and the inertial mass body (30), the switching device (40) being capable of switching between a first path (42) that links the rotary shaft (13) and the inertial mass body (30) with an elastic body (41) intervening therebetween, and a second path (43) that links the rotary shaft (13) and the inertial mass body (30) without the elastic body (41) intervening therebetween. Thus, the vehicular vibration-reduction device (1) achieves the effect of appropriately reducing vibrations.
Patent AU-2012202382-B2 (AU)
Title: STAT3/5 activation inhibitor
Inventor: SEKIGUCHI KAZUO
IPC: C07D317/58
Filed: 2012-04-24
Granted: 2014-06-26
Abstract: C:\NRPortb1\DCC\RBR\421lB15_l.DoC-4/23/2012 An object of the present invention is to provide a STAT3/5 activation inhibitor. The present invention provides a STAT3/5 activation inhibitor containing an 5 aromatic compound represented by the general formula or a salt thereof as an active ingredient: Y-A Xi wherein X1 represents a nitrogen atom or a group -CH=, R1 represents a group -Z-R , in which Z represents a group CO-, a group -CH(OH)- or the like, R6 represents a 5-to 15 membered monocyclic, dicyclic or tricyclic saturated or 15 unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms, R2 represents a hydrogen atom or a halogen atom, Y represents a group -0-, a group -CO-, a group -CH(OH)-or a lower alkylene group, and A represents a group -NHC0 wherein R3 represents a hydrogen atom, a lower alkoxy group or the like, p represents 1 or 2, R4 represents an imidazolyl 25 lower alkyl group or the like.
Patent AU-2012203521-B2 (AU)
Title: Immobilized biologically active entities having a high degree of biological activity
Inventor: CLEEK ROBERT L
IPC: A61L33/08
Filed: 2012-06-15
Granted: 2014-12-18
Abstract: The present invention relates to immobilized biologically active entities having heparin cofactor 11 binding activity. 3437349_1 (GHMatters) P83817 AU.1
Patent AU-2012204163-B2 (AU)
Title: Methods and systems for modifying a parameter of an automated procedure
Inventor: ZINGARETTI GABRIELE
IPC: A61B17/00
Filed: 2012-01-06
Granted: 2015-05-07
Abstract: A variety of systems and methods are described which enable quantitative information to be extracted regarding automated procedures, including those performed at a high speed that may require a user input, without having to interrupt the procedure. In addition, these systems and methods serve to provide information on one or more parameters of the automated procedure, whereby they may be modified, if required, to improve the automated procedure or the results from such a procedure. The systems and methods provided are especially useful in automated hair transplantation procedures.
Patent AU-2012218079-B2 (AU)
Title: Systems for water extraction from air
Inventor: GOELET JOHN
IPC: E03B3/28
Filed: 2012-02-06
Granted: 2017-03-02
Abstract: A system for water extraction from air is provided. The system includes a housing having a plurality of openings allowing an air flow to enter into an inner space defined by the housing. The system also includes a sponge disposed within the inner space defined by the housing. The sponge includes a water absorbing/adsorbing material for absorbing/adsorbing water vapor from the air flow. The system further includes a presser disposed above the sponge and configured to compress the sponge to discharge water from the sponge.
Patent AU-2012241088-B2 (AU)
Title: Label printer
Inventor: VAN COPPENOLLE FRANK
IPC: B41J3/407
Filed: 2012-10-12
Granted: 2014-06-05
Abstract: A cassette comprising at least one locking portion for engaging with a cooperating locking element of a tape printer when said cassette is correctly inserted in said printer, said locking portion comprising a conductive cylindrical bar. There is also disclosed a label printing apparatus in combination with the cassette.
Patent AU-2012252200-B2 (AU)
Title: Method and device for controlling a device for aiding vision
Inventor: LORACH HENRI
IPC: A61F9/08
Filed: 2012-05-11
Granted: 2016-03-03
Abstract: An input signal (f) representative of a scene to be viewed comprises, for each pixel of a matrix of pixels, an event-based asynchronous-signal sequence obtained as a function of variations of light relating to the pixel in the scene. This input signal is transformed spatially within the matrix of pixels and temporally along the signal sequences to generate respective control signals (S) for pixel zones of a device for aiding vision (20).
Patent AU-2012256014-B2 (AU)
Title: Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells
Inventor: KO MINORU S H
IPC: C12N15/63
Filed: 2012-05-11
Granted: 2016-10-27
Abstract: Disclosed herein is the finding that Zscan4 is an early embryonic factor that facilitates cellular reprogramming. In particular, Zscan4 can replace the oncogenic reprogramming factor c- Myc to produce induced pluripotent stem cells when coexpressed with Klf4, Oct4 and Sox2. In addition, several Zscan4-dependent genes were identified that promote iPSC formation when co- expressed with known reprogramming factors. Thus, the present disclosure provides an ex vivo method of producing an iPS cell by reprogramming of a somatic cell. The method includes contacting the somatic cell with a Zscan4, or a Zscan4- dependent gene, and at least one reprogramming factor. Also provided are iPS cells produced by the disclosed method and non- human animals generated from such iPS cells.
Patent AU-2012262127-B2 (AU)
Title: Devices, methods, and graphical user interfaces for document manipulation
Inventor: WEELDREYER CHRISTOPHER DOUGLAS
IPC: G06F3/048
Filed: 2012-05-31
Granted: 2016-01-28
Abstract: An electronic device displays at least a portion of an electronic document with a predefined page layout at a first magnification level on a display; detects a first input indicating a first insertion point in the document, where the first insertion point is proximate to a first portion of text in the document; and in response to detecting the first input: selects a second magnification level different from the first magnification level, where the second magnification level is selected so as to display the first portion of text at a target text display size, and, while maintaining the predefined page layout of the document, displays, at the second magnification level, a portion of the document that includes the first portion of text.
Patent AU-2012272541-B2 (AU)
Title: Hybrid polymeric materials for medical applications and preparation thereof
Inventor: WIESBROCK FRANK
IPC: A61L27/58
Filed: 2012-06-20
Granted: 2015-09-17
Abstract: The present invention relates to a novel polymeric material with enhanced hydrophilicity for medical use comprising a biocompatible polyester material selected from the group consisting of poly(hydroxyalkanoate)s, poly(lactic acid)s, poly(glycolic acid)s, poly(caprolactone)s and copolymers and blends thereof, wherein the biocompatible polyester material is crosslinked with a functionalized poly(alkylene oxide) having at least two functional groups independently selected from the group consisting of azidoformate and alkanoyl azide. The novel polymeric material with enhanced hydrophilicity is useful as a biocompatible material in a variety of medical applications, including medical implants, bioresorbable implants, tissue engineering, and controlled release.
Patent AU-2012296425-B2 (AU)
Title: Yeast-MUC1 immunotherapeutic compositions and uses thereof
Inventor: FRANZUSOFF ALEX
IPC: C12N15/62
Filed: 2012-08-17
Granted: 2017-07-20
Abstract: Disclosed are yeast-based immunotherapeutic compositions comprising mucin- 1 (MUCl), as well as methods for the prevention and/or treatment of cancers characterized by the expression or overexpression of mucin- 1 (MUCl).
Patent AU-2012340846-B2 (AU)
Title: Methods and computing systems for survey data enhancement
Inventor: VERMEER PIETER LEONARD
IPC: G01V1/28
Filed: 2012-11-19
Granted: 2015-04-16
Abstract: Methods and systems are disclosed to enhance surveying techniques. In one embodiment, a virtual response is estimated that corresponds to energy propagated within a subsurface region between a virtual source and a virtual source estimation receiver, wherein the subsurface region corresponds to a survey zone including: a plurality of receivers deployed within the survey zone, a first subzone having at least one actual source, a second subzone within the first subzone; the virtual source is a first receiver disposed in the second subzone; and the virtual source estimation receiver is a second receiver.
Patent AU-2013202044-B2 (AU)
Title: Polyphenylene ether resin composition, and a prepreg and a copper clad laminate made therefrom
Inventor: ZENG XIANPING
IPC: C08G65/48
Filed: 2013-03-27
Granted: 2015-03-12
Abstract: The present invention relates to a polyphenylene ether resin composition, and a prepreg and a copper clad laminate made therefrom. The polyphenylene ether resin composition comprises: (A) functionalized polyphenylene ether resin, 5 (B) crosslinking agent, and (C) initiator; the component (A) functionalized polyphenylene ether resin is polyphenylene ether resin that has a number average molecular weight of 500-5000 and unsaturated double bonds at the molecule terminal; the component (B) crosslinking agent is olefin resin with a number average molecular weight of 500-10000, of which styrene structure 10 comprises 10-50wt%, and of which the molecule comprises 1,2-addition butadiene structure. The polyphenylene ether resin composition of the present invention is a composition of functionalized polyphenylene ether resin with a low molecular weight. The prepreg and copper clad laminate made from the polyphenylene ether resin composition have good dielectric properties and heat 15 resistance.
Patent AU-2013207799-B2 (AU)
Title: Coding parameter sets and NAL unit headers for video coding
Inventor: CHEN YING
IPC: H04N19/31
Filed: 2013-01-11
Granted: 2017-04-20
Abstract: In one example, a video coder, such as a video encoder or video decoder, is configured to code a video parameter set (VPS) for one or more layers of video data, wherein each of the one or more layers of video data refer to the VPS, and code the one or more layers of video data based at least in part on the VPS. The video coder may code the VPS for video data conforming to High-Efficiency Video Coding, Multiview Video Coding, Scalable Video Coding, or other video coding standards or extensions of video coding standards. The VPS may include data specifying parameters for corresponding sequences of video data within various different layers (e.g., views, quality layers, or the like). The parameters of the VPS may provide indications of how the corresponding video data is coded.
Patent AU-2013245539-B2 (AU)
Title: Integrated pump for compressible fluids
Inventor: DALZIEL LINDSAY BRUCE
IPC: F16J15/16
Filed: 2013-10-18
Granted: 2016-06-16
Abstract: Abstract A swash pump for compressible fluids uses sealing contacts made between the nutatable swash plate and the fixed cone plates to centre and locate the inner swash sphere which slides against two resiliently mounted ring seals only, minimising pump friction. A slanted end of a common drive shaft supporting and turned by the rotor of an integrated, variable speed motor causes nutation of the sphere. All bearings, especially axially slidable roller bearings inside the sphere, may settle in position with respect to the common shaft for least frictional loss. This pump is also adapted for pumping explosive gases. WO 2010/047602 PCT/NZ2009/000198 5) keli(26 (1101) (1102)(29 (210) 1306 233 234 223 224 223 e 5(0) 5(g)
Patent AU-2013249336-B2 (AU)
Title: Inhalation devices and systems and methods including the same
Inventor: FLYNN JAMES EDWARD
IPC: A61M15/00
Filed: 2013-04-17
Granted: 2017-06-01
Abstract: A collapsible inhalation device for use with a metered dose inhaler (MDI) dispenser includes an outlet end member, an inlet end member and a tubular, pliable, collapsible sleeve member attached at either end to the inlet and outlet members. The outlet end member includes a mouthpiece. The inlet end member includes an inlet port and an MDI dispenser mount structure configured to receive and engage the MDI dispenser. The inhalation device is positionable in each of an open position, wherein the sleeve member defines a chamber, and a closed position, wherein the sleeve member is collapsed and enveloped by the outlet end member and the inlet end member. When the inhalation device is in the open position with the MDI dispenser mounted in the MDI dispenser mount structure, a dose of the medication can be dispensed from the MDI dispenser into the chamber through the inlet port to mix with air in the chamber and thereby form a mixture of the air and the dose of the medication that can be inhaled by a patient from the chamber through the mouthpiece.
Patent AU-2013273835-B2 (AU)
Title: Timed, pulsatile release systems
Inventor: VENKATESH GOPI
IPC: A61K9/50
Filed: 2013-12-23
Granted: 2016-07-07
Abstract: TIMED, PULSATILE RELEASE SYSTEMS Abstract The invention relates to a pharmaceutical composition comprising one or more populations of timed, pulsatile release beads, wherein at least one population of timed, pulsatile release beads comprises: a) a core particle comprising an acidic active pharmaceutical ingredient or a pharmaceutically acceptable salt thereof; b) an optional inner barrier coating comprising a water insoluble polymer in combination with a water-soluble/pore-forming polymer; and c) an outer lag-time coating comprising a water-insoluble polymer in combination with an enteric polymer wherein the population of timed, pulsatile release beads provides a lag time greater than 6 hours before onset of drug release when tested using USP Apparatus 1 or 2 and a two-stage dissolution medium (first two hours in 700 mL of 0. IN HCl and thereafter in 900 mL at pH 6.8).
Patent AU-2013304795-B2 (AU)
Title: Solid pharmaceutical preparation containing levothyroxine
Inventor: LINDENBLATT HILTRUD
IPC: A61K31/198
Filed: 2013-08-01
Granted: 2017-11-23
Abstract: The invention relates to a solid pharmaceutical preparation comprising levothyroxine sodium, gelatine, citric acid and a filler. The solid pharmaceutical preparation has an improved stability.
Patent AU-2013320199-B2 (AU)
Title: Arrangement of a crusher tooth on a crushing roll of a roll crusher
Inventor: SZCZELINA PIOTR
IPC: E21C35/197
Filed: 2013-09-20
Granted: 2018-03-22
Abstract: The invention relates to an arrangement of a crusher tooth (10) on a crushing roll (1) of a roll crusher and to a corresponding method. A tooth receiving element (11) with an opening (12) is arranged on the crushing roll (1), in which the crusher tooth (10) can be introduced and maintained. According to the invention, a clamping housing (13) in which a shaft (14) of the crushing tooth (10) is received under radial preload of the clamping housing (13) in the opening (12), is provided.
Patent AU-2013372969-B2 (AU)
Title: Multi-function oxygen mask
Inventor: ROLLINS III OFFORD L
IPC: A61M16/06
Filed: 2013-01-10
Granted: 2018-03-08
Abstract: A multi-function oxygen mask is disclosed which generally comprises a mask body and a gas delivery adapter. The mask body forms an internal cavity configured to cover a nose and mouth of a patient. A nasal chamber is formed in the upper portion of the mask body, the nasal chamber includes an upper portion, a lower portion and a gas delivery adapter aperture adjacent the lower portion of the nasal chamber. An access aperture is formed through and adjacent to the lower portion of the mask body. The access aperture is configured to permit access to the mouth of a patient. The gas delivery adapter has a general tubular structure and includes a first end and opposing second end, the first end of the gas delivery adapter is coupled to the gas delivery adapter aperture. An oxygen supply port radially extends outward from the gas delivery adapter and adjacent to the first end of the gas delivery adapter. The oxygen supply port further includes an external inlet portion, an outlet portion positioned within a volumetric space of the gas delivery adapter and a diverter member adjacent to the outlet portion. The diverter member is configured to direct a flow towards the first end of the gas delivery adapter. A meter-dose inhaler port radially extends outward from the gas delivery adapter. Finally, the gas delivery adapter includes a meter-dose inhaler port and a nebulizer port.
Patent AU-2014201077-B2 (AU)
Title: Method for producing highly pure platinum powder, as well as platinum powder that can be obtained according to said method, and use thereof
Inventor: KRALIK JOACHIM
IPC: C22B11/00
Filed: 2014-02-28
Granted: 2015-08-13
Abstract: Method for producing highly pure platinum powder, as well as platinum powder that can be obtained according to said method, and use thereof Abstract A subject matter of the invention is a method for producing highly pure platinum on an industrial scale, as well as the use of said highly pure platinum. According to the method according to the invention, a hexahalogenoplatinate is reduced to platinum in acidic conditions. (8376618_1):RTK
Patent AU-2014210247-B2 (AU)
Title: Ring wing floating platform
Inventor: WU ZHIRONG
IPC: B63B35/44
Filed: 2014-01-22
Granted: 2016-02-11
Abstract: A ring wing floating platform comprising: a floatation body, where the top part thereof is elevated above seawater level; a ring wing surrounding the periphery of the bottom part of the floatation body, where the bottom part of the ring wing is in flush with the bottom part of the floatation body, annular gaps are provided along the radial direction, and the ring wing and the floatation body form an integral structure via multiple connection structures distributed in the radial direction; a positioning system arranged at the bottom part of the floatation body; and, a topside facility arranged on top of the floatation body. The ring wing floatation platform is applicable for oilfield and gas field exploration, development, and production in deepwater and adverse sea conditions, and is a system that is environmentally friendly, safe and reliable, flexible to use, and convenient to transport. All construction and commissioning works for the entire platform can be completed in a shipyard, thus greatly conserving facility construction costs, oil and gas field production operating costs, and disposal costs.
Patent AU-2014243795-B2 (AU)
Title: Treated metathesis substrate materials and methods of making and using the same
Inventor: VARGA JENO
IPC: C07C6/02
Filed: 2014-03-13
Granted: 2018-03-29
Abstract: A method for treating a substrate prior to a metathesis reaction includes treating the substrate with a first agent configured to mitigate potentially adverse effects of one or more contaminants in the substrate on a catalyst used to catalyze the metathesis reaction. The treating reduces a level of the one or more contaminants by an amount sufficient to enable the metathesis reaction to proceed at a substrate-to-catalyst molar ratio of at least about 7,500 to 1. Methods for metathesizing substrates are described.
Patent AU-2014265015-B2 (AU)
Title: Gaming machine
Inventor: MIZUE HAYATO
IPC: A63F13/00
Filed: 2014-11-18
Granted: 2015-07-30
Abstract: GAMING MACHINE In a gaming machine including a symbol region (31) where reels having symbols (33) are arranged in predetermined arrangement, so that the symbols (33) are displayed in an arranged manner in longitudinal and transverse directions, there are provided a reel control unit that independently controls movement and stop of each of the reels, such that the symbols (33) appearing in the symbol region (31) change and a winning determination unit that determines whether the symbols appearing on a valid line set to span the reels form a predetermined winning pattern, when each of the reels is stopped, layers are set in the symbol region, and in the gaming machine, at least one reel is disposed in each layer, a symbol group is provided in at least one specific reel arranged in a specific layer of the layers in such a manner that symbols capable of forming at least portion of the winning pattern are arranged in the symbol group, at least one of the symbols capable of forming at least portion of the winning pattern overlaps the other reel in the other layer different from the specific layer, and that the symbol group move integrally with the specific reel, the symbols that are disposed in the symbol group in the specific reel can be viewed from a player, and when the symbol group is stopped on the valid line, the winning determination unit make the symbols disposed in the symbol group be included in a determination target and determines whether the winning pattern is formed.
Patent AU-2014269901-B2 (AU)
Title: Endoscope reprocessing system and method
Inventor: TERLIUC GAD
IPC: B08B3/00
Filed: 2014-05-21
Granted: 2019-01-03
Abstract: A method for reprocessing a balloon endoscope, the method including the steps of deflating a balloon of a balloon endoscope to a negative pressure state following clinical use thereof and thereafter maintaining the interior of the balloon in a negative pressure state during at least part of reprocessing the balloon endoscope.